RxDoctor Payments Data

Daniel Hayes

Medical Oncology · Ann Arbor, MINPI 1124184965

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $22,710 of the $26,545 with a category attached, or 85.6%. Cepheid accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $10,318 and has fallen 59.0% since, to $4,230 in 2024.

$26,545in general payments, 2019–2025

Across 17 payments — averaging $1561.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$26K
  • Menarini Silicon Biosystems, Inc.$131
$1,713,009in research payments, 2019–2025

Across 80 payments — averaging $21,413 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Menarini Silicon Biosystems, Inc.$1.2M
  • Cepheid$474K
  • Macrogenics, Inc.$5K
  • Merck$492

What the payments were for

  • Consulting fees$22,71086%
  • Travel & lodging$3,46413%
  • Food & beverage$3711%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cepheid15$26,414
Menarini Silicon Biosystems, Inc.2$131

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,545 in reported general payments places this provider in the 80th percentile of 170 medical oncology providers in Michigan.

See all medical oncology providers in Michigan

Other medical oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →